394 related articles for article (PubMed ID: 18370448)
1. Bupropion: a review of its use in the management of major depressive disorder.
Dhillon S; Yang LP; Curran MP
Drugs; 2008; 68(5):653-89. PubMed ID: 18370448
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on bupropion in major depressive disorder.
Dhillon S; Yang LP; Curran MP
CNS Drugs; 2008; 22(7):613-7. PubMed ID: 18547129
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
[TBL] [Abstract][Full Text] [Related]
4. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
5. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
Leuchter AF; Lesser IM; Trivedi MH; Rush AJ; Morris DW; Warden D; Fava M; Wisniewski SR; Luther JF; Perales M; Gaynes BN; Stewart JW
J Psychiatr Pract; 2008 Sep; 14(5):271-80. PubMed ID: 18832958
[TBL] [Abstract][Full Text] [Related]
6. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Rush AJ; Trivedi MH; Wisniewski SR; Stewart JW; Nierenberg AA; Thase ME; Ritz L; Biggs MM; Warden D; Luther JF; Shores-Wilson K; Niederehe G; Fava M;
N Engl J Med; 2006 Mar; 354(12):1231-42. PubMed ID: 16554525
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.
Llorca PM; Fernandez JL
Int J Clin Pract; 2007 Apr; 61(4):702-10. PubMed ID: 17394446
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram: a review of its use in the management of major depressive disorder in adults.
Garnock-Jones KP; McCormack PL
CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
[TBL] [Abstract][Full Text] [Related]
11. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.
Thase ME; Haight BR; Richard N; Rockett CB; Mitton M; Modell JG; VanMeter S; Harriett AE; Wang Y
J Clin Psychiatry; 2005 Aug; 66(8):974-81. PubMed ID: 16086611
[TBL] [Abstract][Full Text] [Related]
12. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
13. Venlafaxine extended-release: a review of its use in the management of major depression.
Wellington K; Perry CM
CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF; Plosker GL
Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
[TBL] [Abstract][Full Text] [Related]
15. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
Einarson TR; Arikian SR; Casciano J; Doyle JJ
Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
[TBL] [Abstract][Full Text] [Related]
16. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
Whyte EM; Basinski J; Farhi P; Dew MA; Begley A; Mulsant BH; Reynolds CF
J Clin Psychiatry; 2004 Dec; 65(12):1634-41. PubMed ID: 15641868
[TBL] [Abstract][Full Text] [Related]
17. Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?
Gerra ML; Marchesi C; Amat JA; Blier P; Hellerstein DJ; Stewart JW
J Clin Psychiatry; 2014 Sep; 75(9):e939-44. PubMed ID: 25295437
[TBL] [Abstract][Full Text] [Related]
18. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.
DeVane CL
J Clin Psychiatry; 2003; 64 Suppl 18():14-9. PubMed ID: 14700450
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and tolerability of bupropion in the treatment of major depressive disorder.
Moreira R
Clin Drug Investig; 2011 Oct; 31 Suppl 1():5-17. PubMed ID: 22015858
[TBL] [Abstract][Full Text] [Related]
20. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
